Isoniazid-induced peripheral neuritis is more common in which patient?
Cross-resistance between antimicrobial agents can be unidirectional or bidirectional. Unidirectional cross-resistance is observed in which of the following pairs?
What is the drug of choice for secondary syphilis?
Which of the following anti-tuberculosis (ATT) drugs can be used in patients with hepatic dysfunction?
Which cephalosporin possesses anti-pseudomonal activity?
What is the drug of choice for the exo-erythrocytic stage of malaria?
Which of the following is NOT an adverse effect of Amphotericin B?
What is the drug of choice for treating infections caused by methicillin-resistant Staphylococcus aureus?
Which antifungal drug acts as an anti-metabolite?
Actinomycosis is sensitive to which of the following antimicrobial agents?
Explanation: **Explanation:**1. Why Slow Acetylators is the Correct Answer:Isoniazid (INH) is metabolized in the liver primarily by the enzyme **N-acetyltransferase 2 (NAT2)** via acetylation [1, 2]. In **slow acetylators**, the metabolism of INH is significantly delayed, leading to higher plasma concentrations of the drug [1].INH promotes the excretion of **Pyridoxine (Vitamin B6)** and inhibits the enzyme pyridoxine kinase, which converts B6 to its active form (pyridoxal phosphate) [1]. Higher levels of INH in slow acetylators result in a more profound deficiency of Vitamin B6. Since Vitamin B6 is essential for myelin synthesis and neurotransmitter metabolism, its deficiency manifests clinically as **peripheral neuritis** [1, 3].2. Why the Other Options are Incorrect:* **Fast Acetylators:** These individuals metabolize INH rapidly. While they are less prone to peripheral neuropathy, they are at a higher risk of **INH-induced hepatotoxicity** because they produce the toxic metabolite (acetylhydrazine) more quickly.* **Slow/Fast Oxidizers:** These terms refer to the Cytochrome P450 system (oxidation). While INH can inhibit certain CYP enzymes (like CYP2C19 and CYP3A4), its primary metabolic pathway is **acetylation**, not oxidation. Therefore, "oxidizer" status is not the determining factor for INH-induced neuropathy.3. NEET-PG High-Yield Pearls:* **Prophylaxis:** Peripheral neuritis can be prevented by co-administering **Pyridoxine (10–100 mg/day)** [1].* **Genetic Polymorphism:** Acetylator status is a classic example of pharmacogenetic variation [2].* **Other Side Effects:** INH is known for the triad of **Hepatotoxicity, Neurotoxicity, and Lupus-like syndrome** (the latter also more common in slow acetylators).* **Drug Interaction:** INH is a potent **enzyme inhibitor**, which can increase levels of drugs like Phenytoin and Carbamazepine.
Explanation: ### Explanation **1. Why Neomycin and Streptomycin is Correct:** Cross-resistance occurs when resistance to one drug leads to resistance to another, usually within the same class. * **Unidirectional cross-resistance** means that resistance to drug 'A' confers resistance to drug 'B', but resistance to drug 'B' does not necessarily mean the organism is resistant to drug 'A'. * In the case of aminoglycosides, **Neomycin** is highly potent and susceptible to a wider array of bacterial inactivating enzymes compared to **Streptomycin**. Bacteria that develop resistance to Neomycin (often through multiple enzyme pathways) almost always show resistance to Streptomycin. However, bacteria resistant to Streptomycin (often via a single ribosomal mutation) frequently remain sensitive to Neomycin [1]. Therefore, the resistance flows in one direction. **2. Why Other Options are Incorrect:** * **B. Tetracycline and Doxycycline:** These exhibit **bidirectional (complete) cross-resistance**. The primary mechanism of resistance is the efflux pump (Tet-A) or ribosomal protection proteins, which generally affect all members of the tetracycline class simultaneously. * **C. Sulphadiazine and Sulphadoxine:** These are both Sulfonamides [3]. Resistance involves an alteration in the enzyme dihydropteroate synthase (DHPS). This mechanism provides **bidirectional cross-resistance** across the entire sulfonamide group [2]. **3. NEET-PG High-Yield Pearls:** * **Aminoglycosides:** Resistance is most commonly due to **R-factor mediated acquisition of inactivating enzymes** (adenylyltransferases, phosphoryltransferases, etc.). * **Gentamicin vs. Amikacin:** This is another classic example of unidirectional resistance. Amikacin is resistant to most aminoglycoside-inactivating enzymes; thus, Gentamicin-resistant strains are often sensitive to Amikacin, but Amikacin-resistant strains are almost always resistant to Gentamicin. * **Clinical Rule:** Always use the most "vulnerable" or narrow-spectrum drug first to preserve the efficacy of broader agents for later use.
Explanation: The drug of choice for all stages of syphilis (primary, secondary, and early latent) is **Benzathine Penicillin G**. Syphilis is caused by the spirochete *Treponema pallidum*, which remains highly sensitive to Penicillin. **Why Benzathine Penicillin is the Correct Choice:** *Treponema pallidum* has a very slow multiplication time (30–33 hours). To achieve a cure, the antibiotic concentration must be maintained above the minimum inhibitory concentration (MIC) for an extended period. Benzathine Penicillin is a **long-acting repository form** administered intramuscularly; a single dose of 2.4 million units provides sustained therapeutic blood levels for up to 3 weeks, effectively covering multiple replication cycles of the organism. **Analysis of Incorrect Options:** * **Chloramphenicol (A):** It is a bacteriostatic drug primarily used for enteric fever or meningitis in patients with severe allergies [2]; it has no role in the standard treatment of syphilis. * **Doxycycline (C):** While effective against *T. pallidum* [2], it is considered a **second-line alternative** only for non-pregnant patients with a penicillin allergy. It requires a 14-day course, leading to lower compliance compared to a single injection. * **Vancomycin (D):** This is a glycopeptide used for Gram-positive infections like MRSA [1]; it is not effective against spirochetes. **High-Yield Clinical Pearls for NEET-PG:** * **Jarisch-Herxheimer Reaction:** A common systemic reaction (fever, headache, myalgia) occurring within hours of the first penicillin dose due to the release of endotoxins from dying spirochetes. It is managed with aspirin/NSAIDs. * **Neurosyphilis:** Benzathine penicillin does not cross the blood-brain barrier. Therefore, **Aqueous Crystalline Penicillin G** (IV) is the drug of choice for neurosyphilis. * **Pregnancy:** Penicillin is the only recommended treatment. If a pregnant woman is allergic, she must undergo **desensitization** and then be treated with penicillin.
Explanation: **Explanation:** The management of tuberculosis in patients with pre-existing liver disease requires a clear distinction between hepatotoxic and non-hepatotoxic drugs. **Why Streptomycin is the Correct Answer:** Streptomycin is an aminoglycoside that is primarily excreted unchanged by the **kidneys** via glomerular filtration. Unlike most first-line ATT drugs, it does not undergo hepatic metabolism and is **not hepatotoxic**. Therefore, it is the safest first-line agent to use in patients with hepatic dysfunction or chronic liver disease. **Analysis of Incorrect Options:** The remaining first-line ATT drugs are known for their potential to cause drug-induced liver injury (DILI): * **Pyrazinamide (C):** This is the **most hepatotoxic** drug among the first-line agents. It is strictly avoided or used with extreme caution in liver disease. * **Isoniazid (B):** It is metabolized in the liver via acetylation. It can cause both asymptomatic elevation of transaminases and severe hepatitis. * **Rifampicin (D):** It is a potent inducer of hepatic microsomal enzymes and can cause cholestatic jaundice. When combined with INH, the risk of hepatotoxicity increases synergistically. **NEET-PG High-Yield Pearls:** * **Hepatotoxicity Ranking:** Pyrazinamide > Isoniazid > Rifampicin (P > I > R). * **Safe Drugs in Liver Disease:** Streptomycin and Ethambutol are the two first-line drugs that are not hepatotoxic. * **Clinical Protocol:** In patients with unstable liver disease, the WHO-recommended regimen often consists of **"SHE"** (Streptomycin, Ethambutol, and a Quinolone) or avoiding PZA entirely. * **Monitoring:** ATT should be withheld if Serum Bilirubin > 2 mg/dL or if ALT/AST levels are > 3 times the upper limit of normal (with symptoms) or > 5 times (without symptoms).
Explanation: **Explanation:**Cephalosporins are classified into generations based on their spectrum of activity [2]. The ability to cover *Pseudomonas aeruginosa* is a critical clinical distinction found primarily in specific **third and fourth-generation** agents.**Why Cefoperazone is correct:**Cefoperazone is a third-generation cephalosporin known for its potent anti-pseudomonal activity. Along with **Ceftazidime**, it is one of the two classic third-generation agents used to treat *Pseudomonas* infections [1]. A unique pharmacokinetic feature of Cefoperazone is its primary excretion through **bile** [2], making it useful in patients with renal failure but also increasing the risk of biliary sludge and a disulfiram-like reaction.**Why the other options are incorrect:*** **Cefazolin (Option A):** A first-generation cephalosporin [1], [2]. It has excellent Gram-positive coverage (especially *S. aureus*) but lacks the complexity to penetrate the outer membrane of *Pseudomonas* [1].* **Ceftriaxone (Option C):** While it is a third-generation cephalosporin with a broad Gram-negative spectrum, it notably **lacks activity** against *Pseudomonas* [1]. It is the drug of choice for meningitis and gonorrhea.* **Cefuroxime (Option B):** A second-generation cephalosporin [2]. It is effective against *H. influenzae* and *Moraxella*, but has no anti-pseudomonal efficacy [2].**High-Yield NEET-PG Pearls:**1. **Anti-pseudomonal Cephalosporins:** Ceftazidime (3rd gen), Cefoperazone (3rd gen), and Cefepime (4th gen) [1].2. **Biliary Excretion:** Cefoperazone and Ceftriaxone are the two cephalosporins that do not require dose adjustment in renal failure [2].3. **Side Effects:** Cefoperazone can cause hypoprothrombinemia (Vitamin K deficiency) and disulfiram-like reactions due to its methylthiotetrazole (MTT) side chain.
Explanation: The life cycle of the malaria parasite involves different stages, and drugs are classified based on which stage they target. The **exo-erythrocytic (EE) stage** refers to the phase where parasites (sporozoites) infect and multiply within the liver cells before entering the bloodstream.Why Primaquine is the Correct Answer:Primaquine is a tissue schizonticide. It is uniquely effective against the liver stages of all malaria species. Most importantly, it is the only drug capable of killing **hypnozoites** (the dormant liver stages) of *Plasmodium vivax* and *Plasmodium ovale* [1]. Therefore, it is the drug of choice for **radical cure** to prevent relapses.Analysis of Incorrect Options:* **Chloroquine:** A potent blood schizonticide [2]. It is highly effective against the erythrocytic (red blood cell) stage but has **no activity** against the exo-erythrocytic/liver stage.* **Proguanil:** While it has some causal prophylactic activity against the pre-erythrocytic stage, it is primarily used in combination (e.g., with Atovaquone) and is not the primary drug for eliminating established liver stages or hypnozoites.* **Mefloquine:** Like Chloroquine, this is a blood schizonticide used for prophylaxis and treatment of resistant malaria [1]. It does not eliminate the liver stages.High-Yield Clinical Pearls for NEET-PG:* **G6PD Deficiency:** Before prescribing Primaquine, patients **must** be screened for G6PD deficiency, as the drug can cause life-threatening acute hemolysis in these individuals.* **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the G6PD status of the fetus cannot be determined.* **Tafenoquine:** A newer long-acting analog of Primaquine that also targets the EE stage and can be given as a single dose.* **Gametes:** Primaquine also has gametocidal action against all species, including *P. falciparum*, helping prevent the transmission of malaria [1].
Explanation: **Explanation:** Amphotericin B is a potent antifungal that acts by binding to ergosterol in the fungal cell membrane, creating pores that lead to the leakage of intracellular contents [1]. However, it also binds to cholesterol in human cells, leading to significant systemic toxicity. **Why Hyperkalemia is the correct answer:** Amphotericin B is notoriously nephrotoxic [2]. It causes **renal tubular acidosis (Type 1)** and increases the permeability of the distal tubule. This leads to a profound wasting of electrolytes, specifically resulting in **Hypokalemia** (low potassium) and **Hypomagnesemia**, rather than hyperkalemia. Hyperkalemia is therefore not an adverse effect; in fact, potassium supplementation is often required during therapy. **Analysis of other options:** * **Hepatotoxicity:** While less common than nephrotoxicity, Amphotericin B can cause liver enzyme elevations and hepatic dysfunction. * **Thrombocytopenia:** Bone marrow suppression leading to anemia (most common), thrombocytopenia, and leukopenia can occur with prolonged use. * **Arrhythmias:** These can occur due to rapid infusion (infusion-related reaction) [2] or secondary to the severe electrolyte imbalances (hypokalemia/hypomagnesemia) caused by the drug. **NEET-PG High-Yield Pearls:** 1. **Nephrotoxicity** is the dose-limiting toxicity [2]. It can be minimized by "saline loading" (pre-infusion of 0.9% NaCl). 2. **Liposomal Amphotericin B** is preferred as it has reduced nephrotoxicity due to targeted delivery [1]. 3. **Infusion-related reactions** ("Shake and Bake"): Fever, chills, and rigors are common [2]. Pre-medication with NSAIDs, antihistamines, or hydrocortisone is often practiced. 4. **Anemia** caused by Amphotericin B is due to decreased erythropoietin production by the damaged kidneys.
Explanation: **Explanation:** **1. Why Glycopeptides are correct:** Methicillin-resistant *Staphylococcus aureus* (MRSA) is resistant to almost all beta-lactam antibiotics due to an alteration in the target site—the **PBP-2a (Penicillin Binding Protein 2a)**, encoded by the *mecA* gene. This structural change prevents beta-lactams from binding to the cell wall. **Vancomycin**, a glycopeptide, remains the gold standard and drug of choice for MRSA. It works by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan chain, physically blocking cell wall synthesis. Since its mechanism does not involve PBPs, it bypasses the resistance mechanism of MRSA. **2. Why other options are incorrect:** * **Macrolides (e.g., Erythromycin):** These inhibit protein synthesis (50S subunit). However, MRSA strains frequently harbor *erm* genes that confer cross-resistance to macrolides, making them unreliable. * **Third-generation Cephalosporins (e.g., Ceftriaxone):** Like most beta-lactams, these cannot bind to the altered PBP-2a of MRSA. (Note: Ceftaroline, a 5th generation cephalosporin, is the only exception that covers MRSA). * **Carbapenems (e.g., Imipenem):** Despite being broad-spectrum, they are ineffective against MRSA for the same reason—lack of affinity for PBP-2a. **3. NEET-PG High-Yield Pearls:** * **Red Man Syndrome:** A common side effect of Vancomycin due to rapid histamine release (prevented by slow infusion). * **Alternative for MRSA:** If Vancomycin resistance (VRSA) or intolerance occurs, **Linezolid** (an Oxazolidinone) or **Daptomycin** (a Lipopeptide) are used. * **Daptomycin Caution:** It is **not** used for MRSA pneumonia because it is inactivated by pulmonary surfactant. * **DOC for MRSA Screening/Decolonization:** Topical **Mupirocin** applied to the nares.
Explanation: **Explanation:** **Flucytosine (5-FC)** is the correct answer because it is a pyrimidine antimetabolite. Its mechanism of action involves being taken up by fungal cells via the enzyme **cytosine permease**. Once inside, it is converted by **cytosine deaminase** into **5-fluorouracil (5-FU)**. This metabolite is further processed into 5-fluorodeoxyuridylic acid, which inhibits **thymidylate synthase**, thereby halting DNA synthesis. Since human cells lack cytosine deaminase, the drug exhibits selective toxicity. **Analysis of Incorrect Options:** * **Ketoconazole:** An imidazole derivative that inhibits the enzyme **14-α-demethylase**, preventing the conversion of lanosterol to ergosterol, thereby disrupting cell membrane synthesis. * **Terbinafine:** An allylamine that inhibits **squalene epoxidase**, leading to an accumulation of squalene (toxic) and a deficiency of ergosterol. * **Griseofulvin:** An antifungal that interferes with **microtubule function**, disrupting the mitotic spindle and inhibiting fungal mitosis. **NEET-PG High-Yield Pearls:** * **Synergy:** Flucytosine is rarely used alone due to rapid resistance development; it is most commonly combined with **Amphotericin B** for Cryptococcal meningitis. * **Side Effects:** The most significant dose-limiting toxicity is **bone marrow suppression** (anemia, leukopenia, thrombocytopenia) due to the conversion of 5-FC to 5-FU by intestinal flora. * **Spectrum:** It is primarily active against *Cryptococcus neoformans* and *Candida* species.
Explanation: **Explanation:** **Actinomycosis** is a chronic granulomatous infection caused by *Actinomyces israelii*, which are gram-positive, anaerobic, filamentous bacteria (not fungi, despite the name). 1. **Why Penicillin is Correct:** **Penicillin G** is the drug of choice for all forms of actinomycosis. Because the infection often presents with dense fibrosis and "sulfur granules," high doses are required over a prolonged period (weeks to months) to ensure adequate tissue penetration. For patients allergic to penicillin, tetracyclines or erythromycin are suitable alternatives. 2. **Why Other Options are Incorrect:** * **Streptomycin (Option A):** This is an aminoglycoside primarily used for aerobic gram-negative bacteria and *Mycobacterium tuberculosis*. It is ineffective against the anaerobic *Actinomyces*. * **Nystatin (Option B):** This is a polyene antifungal. Since *Actinomyces* are true bacteria (lacking ergosterol in their cell walls), antifungal agents have no effect on them. * **Iodoxuridine (Option C):** This is an antiviral agent (pyrimidine analog) used topically for Herpes Simplex Keratitis. It has no antibacterial properties. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** *Actinomyces* are often described as "branching filamentous bacteria." * **Diagnosis:** Look for **"Sulfur Granules"** in the discharge (yellowish clumps of organisms). * **Common Presentation:** "Lumpy Jaw" (Cervicofacial actinomycosis) following dental procedures or poor oral hygiene. * **Key Distinction:** Do not confuse *Actinomyces* (anaerobic, treated with Penicillin) with *Nocardia* (aerobic, acid-fast, treated with Sulfonamides/TMP-SMX). A common mnemonic is **SNAP**: **S**ulfa for **N**ocardia, **A**ctinomyces gets **P**enicillin.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free